← Back to Search

Symptom Management Service (SMS) Consultation for Cancer

N/A
Waitlist Available
Led By Stephanie Cheng, MD
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be able to speak and read English
Carry a diagnosis of an advanced solid tumor cancer (locally advanced or metastatic, i.e., stage III or IV cancer)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 3 months
Awards & highlights

Study Summary

This trial is investigating whether combining palliative care with psycho-oncology is possible and beneficial for patients with advanced cancer.

Eligible Conditions
  • Cancer
  • Solid Tumors

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Adherence rate
Develop Categories for intervention refinement (Phase 1)
Frequency of Participant Ineligibility Reason
+5 more
Secondary outcome measures
Change in distress score on the Edmonton Symptom Assessment System (ESAS)
Change in score on the Cancer Behavior Inventory-Brief (CBI-B)
Change in score on the Functional Assessment of Cancer Therapy- General (FACT-G)
+7 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Phase 2: Refined GMVExperimental Treatment4 Interventions
Up to three new cohorts of participants are recruited to assess the acceptability and feasibility of the refined intervention based on the results from the Phase 1 group
Group II: Phase 1: Supportive care (GMV)Experimental Treatment4 Interventions
Participants will take a baseline assessment to collect socio-demographic information and complete a series of patient-reported outcome assessments (PROs) prior to their first group medical visit (GMV). The GMV intervention will take place over four weekly sessions conducted virtually. At the completion of all four weekly GMV sessions, participants will be asked to complete an exit survey. Participants in phase one will not be contacted or followed after the exit survey.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Support Group Therapy
2021
N/A
~80
Symptom Management Service (SMS) Consultation
2021
N/A
~30

Find a Location

Who is running the clinical trial?

University of California, San FranciscoLead Sponsor
2,492 Previous Clinical Trials
11,930,750 Total Patients Enrolled
Stephanie Cheng, MDPrincipal InvestigatorUniversity of California, San Francisco
4 Previous Clinical Trials
565 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the fundamental aims of this research?

"The primary goal of this 14 day trial is to measure the rate of retention. Secondary objectives include an appraisal of Quality Of Life, Generalized Anxiety Disorder (GAD-7) assessment and Patient Reported Outcome Measurement Information System's Fatigue - Short Form 6a. These assessments involve a series of questions with responses ranging from 1 to 10 or 1 to 5, depending on the metric being measured; in some cases higher scores indicate greater fatigue while in other cases lower numbers signify more severe symptoms."

Answered by AI

How many participants are being observed for this research endeavor?

"Affirmative. Clinicaltrials.gov provides evidence that this clinical study is actively recruiting participants, having been posted on January 26th 2021 and recently updated on May 12th 2022. 32 patients are required for the trial at one medical centre."

Answered by AI

Are there any openings for participants in this clinical experiment?

"Affirmative. Clinicaltrials.gov states that the research is actively recruiting participants, with 32 people expected to take part across a single institution. This scientific exploration was initially posted on January 26th 2021 and its information was last edited on May 12th 2022."

Answered by AI
~7 spots leftby Mar 2025